Advertisement Misonix signs new distribution agreement with Ekrior Lda - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Misonix signs new distribution agreement with Ekrior Lda

Misonix, a developer of minimally invasive ultrasonic medical device technology, has entered into a new, three year, exclusive distribution agreement with Ekrior Lda, a division of Avanco Sistemas Medicos, based in Barcarena, Portugal, for the distribution of the SonaStar ultrasonic surgical aspirator, the BoneScalpel ultrasonic bone cutter, and the SonicOne ultrasonic wound debrider.

The agreement provides Ekrior with the rights to sell in Portugal, and includes minimum purchase requirements.

According to Misonix, the SonaStar is used by neuro and general surgeons for quick and efficient removal of both hard and soft tumors while sparing most vessels. The BoneScalpel is a tissue specific osteotomy device capable of making precise cuts through bone and hard tissue while largely preserving delicate soft tissue structures. It offers the convenience and speed of a power instrument without the danger associated with rotary sharps.

The SonicOne is an ultrasonic wound care system that offers tissue specific debridement and cleansing for effective removal of devitalized tissue and fibrin deposits while sparing viable cellular structures.

Michael McManus, Jr, president and CEO of Misonix, said: “Misonix welcomes Ekrior to our growing family of distribution partnerships in Europe. We know Ekrior as a high-profile distributor of advanced technology products in Portugal. We are particularly pleased that they will be distributing three of our product platforms through their well established distribution system.”